| Phase 2 |
| NCT04684147 |
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute… |
Relapsed or Refractory Acute Lymphoblastic Leukemia |
Recruiting |
2025-08-08 |
| NCT04586478 |
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or… |
Non-Hodgkin's Lymphoma |
Recruiting |
2025-02-07 |
| Phase 1/2 |
| NCT05667506 |
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) |
B-cell Acute Lymphoblastic Leukemia |
Recruiting |
2025-08-12 |
| Phase 1 |
| NCT07748533 |
HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. |
Autoimmune Hemolytic Anemia (AIHA) |
Recruiting |
2026-08-05 |
| NCT06826430 |
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus… |
Autoimmune Thrombocytopenia |
Recruiting |
2025-08-07 |
| NCT07091370 |
Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After… |
AIHA - Cold Autoimmune Hemolytic Anemia |
Not Yet Recruiting |
2025-09-22 |
| Early Phase 1 |
| NCT07275736 |
A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune… |
Neurological Autoimmune Diseases |
Recruiting |
2026-03-05 |
| NCT06316791 |
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of… |
Lupus Erythematosus, Systemic |
Recruiting |
2025-02-10 |
| NCT07265206 |
A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune… |
Neurological Autoimmune Diseases |
Not Yet Recruiting |
2025-12-04 |
| Not specified |
| NCT06461351 |
Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection |
B-cell Tumors |
Recruiting |
2025-08-07 |
| NCT06450067 |
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute… |
B-cell Acute Lymphoblastic Leukemia |
Recruiting |
2024-09-19 |